Longwood Fund Ii, L.p. - Net Worth and Insider Trading
Longwood Fund Ii, L.p. Net Worth
The estimated net worth of Longwood Fund Ii, L.p. is at least $0 dollars as of 2024-11-10. Longwood Fund Ii, L.p. is the 10% Owner of Salarius Pharmaceuticals Inc and owns about 0 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $0. Details can be seen in Longwood Fund Ii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Longwood Fund Ii, L.p. has not made any transactions after 2018-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Longwood Fund Ii, L.p.
Longwood Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Longwood Fund Ii, L.p. owns 1 companies in total, including Salarius Pharmaceuticals Inc (SLRX) .
Click here to see the complete history of Longwood Fund Ii, L.p.’s form 4 insider trades.
Insider Ownership Summary of Longwood Fund Ii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2018-10-16 | 10 percent owner |
Longwood Fund Ii, L.p. Latest Holdings Summary
Longwood Fund Ii, L.p. currently owns a total of 1 stock. Longwood Fund Ii, L.p. owns 0 shares of Salarius Pharmaceuticals Inc (SLRX) as of October 16, 2018, with a value of $0.
Latest Holdings of Longwood Fund Ii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLRX | Salarius Pharmaceuticals Inc | 2018-10-16 | 0 | 1.50 | 0 |
Holding Weightings of Longwood Fund Ii, L.p.
Longwood Fund Ii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Longwood Fund Ii, L.p. has made a total of 0 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years. The most-recent trade in Salarius Pharmaceuticals Inc is the sale of 643 shares on October 16, 2018, which brought Longwood Fund Ii, L.p. around $3 Million.
Insider Trading History of Longwood Fund Ii, L.p.
- 1
Longwood Fund Ii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Longwood Fund Ii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Longwood Fund Ii, L.p. is 54.07%. GuruFocus also compares Longwood Fund Ii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Longwood Fund Ii, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Longwood Fund Ii, L.p.'s insider trading performs compared to the benchmark.
Performance of Longwood Fund Ii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 45.01 | | | | | |
| Relative Return to S&P 500(%) | 44.03 | | | | | |
Longwood Fund Ii, L.p. Ownership Network
Ownership Network List of Longwood Fund Ii, L.p.
Ownership Network Relation of Longwood Fund Ii, L.p.
Longwood Fund Ii, L.p. Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Longwood Fund Ii, L.p. is the 10 percent owner of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .
Salarius Pharmaceuticals Inc (SLRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc (SLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc (SLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc (SLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Longwood Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Longwood Fund Ii, L.p.. You might contact Longwood Fund Ii, L.p. via mailing address: 800 Boylston Street, Suite 1555, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
